As of 2025-12-13, the Relative Valuation of BioLife Solutions Inc (BLFS) is (1.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.39 USD, the upside of BioLife Solutions Inc based on Relative Valuation is -105.6%.
The range of the Relative Valuation is (1.48) - (1.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.2x - 29.9x | 26.3x |
| Forward P/E multiples | 13.8x - 20.8x | 14.8x |
| Fair Price | (1.48) - (1.38) | (1.37) |
| Upside | -106.1% - -105.7% | -105.6% |
| Date | P/E |
| 2025-12-12 | -369.01 |
| 2025-12-11 | -373.67 |
| 2025-12-10 | -372.01 |
| 2025-12-09 | -371.71 |
| 2025-12-08 | -374.72 |
| 2025-12-05 | -382.38 |
| 2025-12-04 | -387.93 |
| 2025-12-03 | -383.13 |
| 2025-12-02 | -381.02 |
| 2025-12-01 | -381.63 |
| 2025-11-28 | -398.00 |
| 2025-11-26 | -400.70 |
| 2025-11-25 | -405.36 |
| 2025-11-24 | -395.74 |
| 2025-11-21 | -398.45 |
| 2025-11-20 | -363.45 |
| 2025-11-19 | -366.16 |
| 2025-11-18 | -360.90 |
| 2025-11-17 | -360.60 |
| 2025-11-14 | -361.50 |
| 2025-11-13 | -377.57 |
| 2025-11-12 | -389.29 |
| 2025-11-11 | -391.09 |
| 2025-11-10 | -394.84 |
| 2025-11-07 | -389.44 |
| 2025-11-06 | -405.81 |
| 2025-11-05 | -414.07 |
| 2025-11-04 | -407.16 |
| 2025-11-03 | -418.57 |
| 2025-10-31 | -418.57 |
| 2025-10-30 | -404.00 |
| 2025-10-29 | -413.62 |
| 2025-10-28 | -420.22 |
| 2025-10-27 | -421.12 |
| 2025-10-24 | -432.39 |
| 2025-10-23 | -430.44 |
| 2025-10-22 | -413.62 |
| 2025-10-21 | -415.72 |
| 2025-10-20 | -418.42 |
| 2025-10-17 | -410.31 |
| 2025-10-16 | -416.47 |
| 2025-10-15 | -431.79 |
| 2025-10-14 | -415.42 |
| 2025-10-13 | -411.81 |
| 2025-10-10 | -402.50 |
| 2025-10-09 | -412.26 |
| 2025-10-08 | -410.61 |
| 2025-10-07 | -394.99 |
| 2025-10-06 | -398.30 |
| 2025-10-03 | -399.35 |